vimarsana.com

Latest Breaking News On - Clinical research partners - Page 5 : vimarsana.com

New medical infusion clinic taps into Henrico County market

New medical infusion clinic taps into Henrico County market Photos courtesy of Infusion Solutions) With COVID-19 treatment as part of its offerings, a new clinic focused on infusion therapy is up and running in the region. Infusion Solutions opened in recent months at Glen Forest Office Park. The center features 13 private suites and one common suite, where both adult and child patients can receive outpatient infusion therapy. The 6,000-square-foot center is at 7110 Forest Ave. Infusion therapy is the administration of medications through intravenous or injectable methods. A range of conditions can be treated with infusion therapy such as autoimmune diseases and infections that don’t respond to oral antibiotics, as well as congestive heart failure, osteoporosis and other issues. The center doesn’t offer chemotherapy.

Norfolk
Virginia
United-states
Fredericksburg
Glen-forest
Lucien-roberts
Patrick-oliver
Annette-bennett
Bo-vaughn
Glen-forest-office-park
Clinical-research-partners
Infusion-solutions

Henrico-based researchers launch COVID-19 treatment study

and last updated 2021-03-02 08:50:18-05 HENRICO, Va. Since the fall, Dr. Robert Call, M.D. has led the AstraZeneca COVID-19 vaccine trial at Henrico-based Clinical Research Partners. With 1,800 participants, Call said it s the largest study in the world for the vaccine. Now, researchers are embarking on a new study to help combat the COVID-19 virus. The ACTIVE-2 study will focus on potential COVID-19 therapies that are safe and effective in treating symptoms of the virus. The study, now in phase 2 and 3 of trials, is sponsored by the National Institute of Allergy and Infectious Diseases and The National Institute of Health.

Contact-clinical-research-partners
National-institute-of-health
National-institute-of-allergy
Clinical-research-partners
Robert-call
Henrico-based-clinical-research
National-institute
Infectious-diseases
Chesterfield-county
Virginia
Henrico-county

AstraZeneca/Oxford COVID-19 vaccine study seeking minority participants

AstraZeneca/Oxford COVID-19 vaccine study seeking minority participants More diverse candidates needed for Astrazeneca vaccine study By Karina Bolster | January 11, 2021 at 6:33 PM EST - Updated January 14 at 2:22 PM HENRICO Co., Va. (WWBT) - While a third COVID-19 vaccine is still in the works here in the United States, there is a way you could get that vaccine ahead of time through a clinical study. Clinical Research Partners in Henrico is conducting the AstraZeneca/Oxford COVID-19 vaccine trials in the metro area and desperately needs more people of color to get involved. “African Americans are dying at a much higher rate than our counterparts,” said Dyan Wright, a participant in the study.

United-states
United-kingdom
Americans
American
Astrazeneca-oxford
Dyan-wright
Kamala-harris
Clinical-research-partners
Henrico-co
Clinical-research-partners-in-henrico
Research-partners
Vice-president-elect-kamala-harris

Lohmann: Friends for life and vaccine 'pioneers,' from polio to COVID

They were in second grade in 1954 at St. Catherine’s School when their class was marched across Grove Avenue to Saint Bridget Catholic School. They remember that much. They also remember the somewhat startling sight of nuns in their habits, which made a lasting impression on a pair of little Episcopalian girls. The injections, on the other hand, they really don’t remember much at all. Ashby Roberts and Caroline “Cacky” Winfree were “polio pioneers” — that was on the buttons and certificates they were given. They were part of a nationwide vaccine trial for the polio vaccine developed by Dr. Jonas Salk that involved 1.8 million children, according to the March of Dimes, then known as the National Foundation for Infantile Paralysis, which helped organize the trial.

New-york
United-states
United-kingdom
America
British
Caroline-cacky-winfree
Jonas-salk
Ashby-roberts
Centers-for-disease
Clinical-research-partners
National-foundation-for-infantile-paralysis
Pfizer

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.